Daniel Dube

This inventor holds 30 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Frosst Canada, Inc., Merck Frosst Canada & Co., Actelion Pharmaceuticals Ltd. Active years: 1993-2014.

USPTO Granted Patents = 30 (Patent Applications = 5)

% Patents Active = 50.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 5.8

ph-index = 6

Forward Citations = 232(Granted Patents)

Location History:

Quebec, CA (1995 - 2001)
St-Lazare, CA (1995 - 2011)
Kirkland, CA (2010 - 2011)
Saint-Lazare-de-Vaudreuil, CA (2011)
Saint-Lazare, CA (2012 - 2013)
St. Lazare, CA (1993 - 2014)

Company Filing History:

14 out of 212

Merck Frosst Canada, Inc.

patents

7 out of 80

Merck Frosst Canada & Co.

patents

3 out of 217

Actelion Pharmaceuticals Ltd

Merck Sharp + Dohme Corp.

patents

Years Active: 1993-2014

Loading Chart...

Areas of Expertise:

Renin Inhibitors

PDE4 Inhibitors

COX-2 Inhibitors

Piperidine Derivatives

Quinoline Compounds

Substituted Pyridines

Aminopyridines

Cyclobutenes Derivatives

Leukotriene Biosynthesis

Phenyl Derivatives

Phosphodiesterase Inhibitors

Prostaglandin Receptor Ligands

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8889714 - 3,4-substituted piperidine derivatives as renin inhibitors (2014-11-18),

2. 8343968 - Case of renin inhibitors (2013-01-01),

3. 8334308 - Renin inhibitors (2012-12-18),

4. 8076359 - Renin inhibitors (2011-12-13),

5. 8063105 - Renin inhibitors (2011-11-22),

6. 7968720 - Secondary amines as renin inhibitors (2011-06-28),

7. 7799805 - Piperidine carboxylic acid amide derivatives (2010-09-21),

8. 7482456 - 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors (2009-01-27),

9. 7348433 - Quinolinones as prostaglandin receptor ligands (2008-03-25),

10. 7342024 - 4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors (2008-03-11),

11. 7238706 - 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors (2007-07-03),

12. 7153968 - 8-(biaryl)quinoline PDE4 inhibitors (2006-12-26),

13. 7144896 - Hetero-bridge substituted 8-arylquinoline pde4 inhibitors (2006-12-05),

14. 7060715 - Substituted pyridines as selective cyclooxygenase-2 inhibitors (2006-06-13),

15. 6919353 - Substituted 8-arylquinolune PDE4 inhibitors (2005-07-19),

Title: The Inventor Profile of Daniel Dube from St. Lazare, CA

Introduction: Daniel Dube is a prolific inventor based in St. Lazare, Canada, known for his groundbreaking contributions to various fields.

Latest Patents: Daniel Dube's latest patents include innovative solutions in the tech industry, particularly in the realm of artificial intelligence and renewable energy.

Career Highlights: With a career spanning over two decades, Daniel Dube has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing cutting-edge solutions to address them.

Collaborations: Throughout his career, Daniel Dube has collaborated with leading tech companies and research institutions to bring his inventions to life, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion: Daniel Dube's passion for innovation and his relentless drive to push the boundaries of what is possible make him a standout figure in the world of inventors, with his work continuing to inspire future generations of innovators.